Gurevich M - Search Results

1

The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.

Zilkha-Falb R, Gurevich M, Hayardeny L, Achiron A. Zilkha-Falb R, et al. Among authors: gurevich m. J Neuroimmunol. 2015 Jun 15;283:11-6. doi: 10.1016/j.jneuroim.2015.04.007. Epub 2015 Apr 11. J Neuroimmunol. 2015. PMID: 26004150

2

Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.

Achiron A, Gurevich M. Achiron A, et al. Among authors: gurevich m. Autoimmun Rev. 2006 Oct;5(8):517-22. doi: 10.1016/j.autrev.2006.02.009. Epub 2006 Mar 23. Autoimmun Rev. 2006. PMID: 17027885 Review.

3

Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.

Achiron A, Gurevich M, Snir Y, Segal E, Mandel M. Achiron A, et al. Among authors: gurevich m. Clin Exp Immunol. 2007 Aug;149(2):235-42. doi: 10.1111/j.1365-2249.2007.03405.x. Epub 2007 May 4. Clin Exp Immunol. 2007. PMID: 17488294 Free PMC article.

4

Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathways.

Achiron A, Gurevich M. Achiron A, et al. Among authors: gurevich m. J Neurol Sci. 2009 Nov 15;286(1-2):47-53. doi: 10.1016/j.jns.2009.06.038. Epub 2009 Jul 12. J Neurol Sci. 2009. PMID: 19596127

5

Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.

Gurevich M, Gritzman T, Orbach R, Tuller T, Feldman A, Achiron A. Gurevich M, et al. J Neuroimmunol. 2010 Apr 15;221(1-2):87-94. doi: 10.1016/j.jneuroim.2010.02.010. Epub 2010 Mar 27. J Neuroimmunol. 2010. PMID: 20347159

6

RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.

Achiron A, Zilkha-Falb R, Mashiach R, Gurevich M. Achiron A, et al. Among authors: gurevich m. J Neuroimmunol. 2017 Jan 15;302:41-48. doi: 10.1016/j.jneuroim.2016.10.016. Epub 2016 Nov 17. J Neuroimmunol. 2017. PMID: 27908532

7

Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.

Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. Mandel M, et al. Among authors: gurevich m. Clin Exp Immunol. 2004 Oct;138(1):164-70. doi: 10.1111/j.1365-2249.2004.02587.x. Clin Exp Immunol. 2004. PMID: 15373920 Free PMC article.

8

Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.

Achiron A, Gurevich M, Magalashvili D, Kishner I, Dolev M, Mandel M. Achiron A, et al. Among authors: gurevich m. Clin Dev Immunol. 2004 Sep-Dec;11(3-4):299-305. doi: 10.1080/17402520400001603. Clin Dev Immunol. 2004. PMID: 15559377 Free PMC article.

9

Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.

Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A. Tuller T, et al. Among authors: gurevich m. Genes Immun. 2013 Mar;14(2):67-82. doi: 10.1038/gene.2012.55. Epub 2012 Nov 29. Genes Immun. 2013. PMID: 23190644

10

Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case - control analysis.

Miron G, Gurevich M, Baum S, Achiron A, Barzilai A. Miron G, et al. Among authors: gurevich m. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2055-2061. doi: 10.1111/jdv.14403. Epub 2017 Jul 17. J Eur Acad Dermatol Venereol. 2017. PMID: 28609573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters